Cardiovascular and pancreatic endocrine responses to glucagon-like peptide-1(7-36) amide in the conscious calf

Experimental Physiology

Volumn 82, Issue 4, 1997, Pages 709-716

  Edwards, C M B ^a   Edwards, A V ^b   Bloom, S R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; INSULIN; NITRIC OXIDE; PANCREAS POLYPEPTIDE;

ANIMAL EXPERIMENT; AORTA PRESSURE; ARTICLE; CARDIOVASCULAR FUNCTION; CATTLE; CONTROLLED STUDY; GLUCAGON BLOOD LEVEL; HEART RATE; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN LIKE ACTIVITY; MALE; NEWBORN; NONHUMAN; PANCREAS FUNCTION;

EID: 0030836364     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.1997.sp004059     Document Type: Article

References (23)

1. BARRACAN, J. M., RODRIGUEZ, R. E. & BLAZQUEZ, E. (1994). Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. American Journal of Physiology 266, E459-466.
2. BARRAGAN, J. M., RODRIGUEZ, R. E., ENG, J. & BLAZQUEZ, E. (1996). Interactions of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regulatory Peptides 67, 63 -68.
3. BLACKBURN, A. M., BLOOM, S. R. & EDWARDS, A. V. (1981). Pancreatic endocrine responses to physiological changes in plasma neurotensin concentration. Journal of Physiology 318, 407-412.
4. BLOOM, S. R., EDWARDS, A. V. & GHATEI, M. A. (1983). Endocrine responses to exogenous bombesin and gastrin releasing peptide in conscious calves. Journal of Physiology 344, 37-48.
5. BLOOM, S. R., EDWARDS, A. V. & GHATEI, M. A. (1984). Effects of certain metabolites on pancreaticendocrine responses to gastrin-releasing peptide in conscious calves. Journal of Physiology 346, 547-555.
6. BOWMAN, E. C. J., RODERICK, G. P., BLOOM, S. R. & EDWARDS, A. V. (1997). Role of adrenoceptors in the hypertensive response to feeding in the conscious calf. American Journal of Physiology 272, R601-614.
7. BULLOCK, B. P., HELLER, R. S. & HABENER, J. F. (1996). Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137, 2968-2978.
8. D'ALESSIO, D. A., VOGEL, R., PRIGEON, R., LASCHANSKY, E., KOERKER. D., ENG, J. & ENSINCK, J. W. (1996). Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. Journal of Clinical Investigation 97, 133-138.
9. FIESELER, P., BRIDENBAUGH, S., NUSTEDE, R., MARTELL, J., ØRSKOV, C., HOLST, J. J. & NAUCK, M. A. (1995). Physiological augmentation of amino acid-induced insulin secretion by GIP and GIP-1 but not by CCK-8. American Journal of Physiology 268, E949-955.
10. HOLST, J. J., ØRSKOV, C., VAGN NIELSEN, O. & SCHWARTZ, T. W. (1987). Truncated glucagon-like peptide 1, an insulin-releasing hormone from the distal gut. FEBS Letters 211, 169-174.
11. JONES, C. T., EDWARDS, A. V. & BLOOM, S. R. (1991). Endocrine responses to intra-aortic infusions of acetylcholine in conscious calves. Journal of Physiology 439, 481-499.
12. KOLLIGS, F., FEHMANN, H.-C., GOØKE, R. & GÖKE, B. (1995). Reduction of the incretin ellect in rats by the glucagon-like peplide-1 receptor antagonist exendin (9-39) amide. Diabetes 44, 16-19.
13. KREYMANN, B., WILLIAMS, G., GHATEI, M. A. & BLOOM, S. R. (1987). Glucagon-like peptide-1 (7-36): a physiological incretin in man. Lancet ii, 1300-1304.
14. KREYMANN, B., VIANGOU, Y., KANSK, S., WILLIAMS, G., GHATKI, M. A. & BLOOM, S. R. (1998). Isolation and characterization of GLP-1 (7-36) amide from rat intestine - elevated levels in diabetic rats. FEBS Letters 242, 167-170.
15. LOPEZ, L. C., FRAZIER, M. L., SU, C.-J., KUMAR, A. & SAUNDERS, G. F. (1983). Mammalian pancreatic preproglueagon contains three glucagon-related peptides. Proceedings of the National Academy of of Sciences of the USA 80, 5485-548.
16. MOJSOV, S., HEINRICH, G., WILSON, I. B., RAVAZZOLA, M., ORCI, L. & HABENER, J. (1986). Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. Journal of Biological Chemistry 261, 11880-11889.
17. MOJSOV, S., WEIR, G. C. & HABENER, J. F. (1987). Insulinotropin: glucagon-like pcptide 1(7-37) coencoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. Journal of Clinical Investigation 79, 616-619.
18. NAKABAYASHI, H., NISHIZAWA, M., NAKAGAWA, A., TAKEDA, R. & NIIJIMA, A. (1996). Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. American Journal of Physiology 271, E808-813.
19. NISHIZAWA, M., NAKABAYASHI, H., UCHIDA, K., NAKAGAWA, A. & NIUIMA, A. (1996). The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. Journal of the Autonomic Nervous System 61, 149-154.
20. ØRSKOV, C., HOLST, J. J., KNUHTSEN, S., BALDISERRA, F. G. A., POULSEN, S. S. & VAGN NIELSEN, O. (1986). Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119, 1467-1475.
21. SHIMA, K., HIROTA, M. & OHBOSHI, C. (1988). Effect of glucagon-like peptide-1 on insulin secretion. Regulatory Peptides 22, 245-252.
22. WANG, Z., WANG. R. M., OWJI, A. A., SMITH, D. M., GHATEI, M. A. & BLOOM, S. R. (1995). Glucagonlike peptide-1 is a physiological incretin in rat. Journal of Clinical Investigation 95, 417-421.
23. WEI, Y. & MOJSOV, S. (1996). Tissue-specific expression of the human receptor for glucagon-like peptide-1 - brain, heart and pancreatic forms have the same deduced amino-acid sequence. FEBS Letters 358, 219-224.